Diverse	O
cell	B-Cell
signaling	O
events	O
modulated	O
by	O
perlecan	O
.	O

Perlecan	O
is	O
a	O
ubiquitous	O
pericellular	B-Immaterial_anatomical_entity
proteoglycan	O
ideally	O
placed	O
to	O
mediate	O
cell	B-Cell
signaling	O
events	O
controlling	O
migration	O
,	O
proliferation	O
,	O
and	O
differentiation	O
.	O

Its	O
control	O
of	O
growth	O
factor	O
signaling	O
usually	O
involves	O
interactions	O
with	O
the	O
heparan	O
sulfate	O
chains	O
covalently	O
coupled	O
to	O
the	O
protein	O
core	O
'	O
s	O
N	O
-	O
terminus	O
.	O

However	O
,	O
this	O
modular	O
protein	O
core	O
also	O
binds	O
with	O
relatively	O
high	O
affinity	O
to	O
a	O
number	O
of	O
growth	O
factors	O
and	O
surface	B-Cellular_component
receptors	O
,	O
thereby	O
stabilizing	O
cell	B-Cell
-	O
matrix	B-Cellular_component
links	O
.	O

This	O
review	O
will	O
focus	O
on	O
perlecan	O
-	O
growth	O
factor	O
interactions	O
and	O
describe	O
recent	O
advances	O
in	O
our	O
understanding	O
of	O
this	O
highly	O
conserved	O
proteoglycan	O
during	O
development	O
,	O
cancer	B-Cancer
growth	O
,	O
and	O
angiogenesis	O
.	O

The	O
pro	O
-	O
angiogenic	O
capacities	O
of	O
perlecan	O
that	O
involve	O
proliferative	O
and	O
migratory	O
signals	O
in	O
response	O
to	O
bound	O
growth	O
factors	O
will	O
be	O
explored	O
,	O
as	O
well	O
as	O
the	O
anti	O
-	O
angiogenic	O
signals	O
resulting	O
from	O
interactions	O
between	O
the	O
C	O
-	O
terminal	O
domain	O
known	O
as	O
endorepellin	O
and	O
integrins	O
that	O
control	O
adhesion	O
of	O
cells	B-Cell
to	O
the	O
extracellular	B-Cellular_component
matrix	I-Cellular_component
.	O

These	O
two	O
somewhat	O
diametrically	O
opposed	O
roles	O
will	O
be	O
discussed	O
in	O
light	O
of	O
new	O
data	O
emerging	O
from	O
various	O
fields	O
which	O
converge	O
on	O
perlecan	O
as	O
a	O
key	O
regulator	O
of	O
cell	B-Cell
growth	O
and	O
angiogenesis	O
.	O

